Form 4: Charles River Laboratories Executive Gifts Shares, Maintaining Significant Stake

Joseph W. LaPlume, EVP of Corporate Strategy & Development at Charles River Laboratories, reported gifting 385 shares of common stock, retaining a substantial beneficial ownership of 25,316 shares.

Summary

• Joseph W. LaPlume, Executive Vice President of Corporate Strategy & Development at Charles River Laboratories International, Inc. (CRL), filed a Form 4.
• The filing reports a disposition of 385 shares of Common Stock on June 5, 2025, via a gift (Transaction Code 'G').
• The shares were disposed of at a price of $0, consistent with a gift transaction.
• Following this transaction, Mr. LaPlume beneficially owns 25,316 shares of Charles River Laboratories Common Stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine insider transaction (a gift) and does not reflect positively or negatively on the company's operational or financial performance. The executive retains a substantial holding.

Positives

• The transaction represents a minor change in insider holdings, with the executive retaining a significant stake of 25,316 shares, indicating continued alignment with shareholder interests.

Negatives

• The disposition of shares, even as a gift, slightly reduces the direct ownership of a key executive, though the amount is not material.

Future Outlook

This Form 4 filing pertains solely to an insider stock transaction and does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide insights into broader industry trends or competitive dynamics within the contract research organization (CRO) or life sciences services sector.

Related Party Transactions

• The disposition of shares via a gift (Transaction Code 'G') typically implies a transfer to a family member or charitable organization, which could be considered a related party transaction, though the specific recipient is not disclosed in this filing.

Stakeholder Impact

• Shareholders: Minimal impact as the transaction is small relative to the executive's total holdings and the company's outstanding shares. It indicates a minor reduction in direct insider ownership.
• Employees: No direct impact on employees from this transaction.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders.

Key Dates

Keywords

Charles River Laboratories, CRL, Form 4, Insider Transaction, Stock Gift, Executive Stock Ownership, Joseph W. LaPlume, SEC Filing